Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alnylam Pharmaceuticals
Biotech
Blackstone closes record $6.3B life sciences fund
Investment firm Blackstone closed its $6.3 billion Blackstone Life Sciences VI fund, which is 40% larger than its predecessor.
Will Maddox
Mar 30, 2026 1:50pm
Tenaya, Alnylam ink collab to find gene targets for cardio drugs
Mar 5, 2026 10:56am
Roche sees Alnylam RNAi drug flunk trial, still plans phase 3
Sep 1, 2025 4:39am
City Tx breaks ground with $135M, blueprints from Maraganore
Oct 8, 2024 10:38am
Roche, Alnylam celebrate second ph. 2 win for blood pressure med
Mar 5, 2024 9:05am
Agios' next-up PK med quelled transfusion need in some patients
Nov 20, 2023 11:24am
